JP2019508416A5 - - Google Patents

Download PDF

Info

Publication number
JP2019508416A5
JP2019508416A5 JP2018542732A JP2018542732A JP2019508416A5 JP 2019508416 A5 JP2019508416 A5 JP 2019508416A5 JP 2018542732 A JP2018542732 A JP 2018542732A JP 2018542732 A JP2018542732 A JP 2018542732A JP 2019508416 A5 JP2019508416 A5 JP 2019508416A5
Authority
JP
Japan
Prior art keywords
surgery
pharmaceutical composition
administered
receptor agonist
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018542732A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019508416A (ja
JP7063813B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/053308 external-priority patent/WO2017140684A2/en
Publication of JP2019508416A publication Critical patent/JP2019508416A/ja
Publication of JP2019508416A5 publication Critical patent/JP2019508416A5/ja
Application granted granted Critical
Publication of JP7063813B2 publication Critical patent/JP7063813B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018542732A 2016-02-15 2017-02-14 術後認知機能障害の処置のための方法及び医薬組成物 Active JP7063813B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16305170.9 2016-02-15
EP16305170 2016-02-15
PCT/EP2017/053308 WO2017140684A2 (en) 2016-02-15 2017-02-14 Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction

Publications (3)

Publication Number Publication Date
JP2019508416A JP2019508416A (ja) 2019-03-28
JP2019508416A5 true JP2019508416A5 (cg-RX-API-DMAC7.html) 2020-01-23
JP7063813B2 JP7063813B2 (ja) 2022-05-09

Family

ID=55359484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018542732A Active JP7063813B2 (ja) 2016-02-15 2017-02-14 術後認知機能障害の処置のための方法及び医薬組成物

Country Status (5)

Country Link
US (3) US11484577B2 (cg-RX-API-DMAC7.html)
EP (1) EP3416688B1 (cg-RX-API-DMAC7.html)
JP (1) JP7063813B2 (cg-RX-API-DMAC7.html)
ES (1) ES2930077T3 (cg-RX-API-DMAC7.html)
WO (1) WO2017140684A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020180823A1 (en) * 2019-03-01 2020-09-10 Abrexa Pharmaceuticals, Inc. Compounds for prevention and treatment of post-operative cognitive dysfunction
WO2021222438A1 (en) * 2020-04-28 2021-11-04 Abrexa Pharmaceuticals, Inc. Compounds for prevention and treatment of post-intensive care cognitive dysfunction and cognitive dysfunction resulting from respiratory distress
WO2023211684A2 (en) * 2022-04-29 2023-11-02 Noetix Pharma Llc Prevention and treatment of post-operative cognitive dysfunction (pocd)
US20240238333A1 (en) * 2023-01-12 2024-07-18 Penland Foundation Treatment of delirium using nitrous oxide

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932667A (en) 1971-08-02 1976-01-13 Airco, Inc. Ether compound as an inhalation anesthetic
US3954893A (en) 1971-08-09 1976-05-04 W. R. Grace & Co. New halogenated cyclobutanes
US3987203A (en) 1973-03-16 1976-10-19 Airco, Inc. Anesthetizing composition and method
DE2340561C2 (de) 1973-08-10 1982-12-16 Hoechst Ag, 6000 Frankfurt 2.2.2-Trifluor-1-chloräthyl-äther und Verfahren zu ihrer Herstellung sowie Inhalations-Anästhetikum, das einen dieser Stoffe enthält
DE2340560C2 (de) 1973-08-10 1982-12-16 Hoechst Ag, 6000 Frankfurt 1.2.2.2-Tetrafluoräthyl-äther, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltendes Inhalations-Anästhetikum
US3987100A (en) 1974-04-11 1976-10-19 E. I. Du Pont De Nemours And Company Cyclohexane oxidation in the presence of binary catalysts
US3949005A (en) 1974-05-09 1976-04-06 Airco, Inc. Hexafluoro-t-butyl-difluoromethyl ether as an inhalation anesthetic
US3931344A (en) 1974-08-22 1976-01-06 W. R. Grace & Co. Bromofluorocyclopropanes
US3932529A (en) 1974-12-26 1976-01-13 W. R. Grace & Co. Halocyclopropyl halomethyl ethers
US3995062A (en) 1974-12-26 1976-11-30 W. R. Grace & Co. Halocyclopropyl halomethyl ethers
US3932669A (en) 1975-01-10 1976-01-13 W. R. Grace & Co. 1-Chloro-2,2-dimethyl-1,4,4-trifluorocyclobutane as an anesthetics
US4220644A (en) 1976-05-03 1980-09-02 Smithkline Corporation 7-Acylamino-3-(substituted tetrazolyl thiomethyl) cephalosporins
US4281020A (en) 1979-03-01 1981-07-28 The Dow Chemical Company Deuterated analogues of methoxyflurane useful as an anesthetic
US4346246A (en) 1979-03-12 1982-08-24 Airco, Inc. Process for adjusting the halogen content of halogenated aliphatic ethers
US4262144A (en) 1979-10-25 1981-04-14 The Dow Chemical Company Deuterated isoflurane
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US5391579A (en) 1993-01-28 1995-02-21 University Of Iowa Research Foundation Deuterated sevoflurane as an inhalational anesthetic
EP0690452A3 (en) 1994-06-28 1999-01-07 Advanced Micro Devices, Inc. Electrically erasable memory and method of erasure
CN1283228A (zh) 1997-12-24 2001-02-07 武田药品工业株式会社 多肽、其生产方法及应用
US7635751B2 (en) 2000-03-23 2009-12-22 Takada Pharmaceutical Company Limited Peptides having ligand activities on APJ that is an orphan G protein-coupled receptor, and use thereof
US7947280B2 (en) 2003-05-22 2011-05-24 The Board Of Trustees Of The Leland Stanford Junior University Apelin and uses thereof
US20050112701A1 (en) 2003-09-11 2005-05-26 Aventis Pharma Deutschland Gmbh Test system for the identification of APJ receptor ligands
US8673848B2 (en) 2012-01-27 2014-03-18 Novartis Ag Synthetic apelin mimetics for the treatment of heart failure
US9308232B2 (en) * 2006-06-05 2016-04-12 Keyview Labs, Inc. Compositions and methods for enhancing brain function
EP1903052A3 (en) 2006-07-28 2008-04-02 Faust Pharmaceuticals SA APJ receptor ligands and uses thereof
US20100113570A1 (en) 2008-04-23 2010-05-06 The General Hospital Corporation Prevention and treatment of post-operative cognitive dysfunction
US8946382B2 (en) 2009-02-27 2015-02-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Apelin peptides and methods of use
US20120316247A1 (en) 2009-10-20 2012-12-13 The General Hospital Corporation Prevention and treatment of post-operative cognitive dysfunction (pocd)
DK2547363T3 (da) * 2010-02-17 2020-09-07 The Kennedy Trust For Rheumatology Res Fremgangsmåder til forebyggelse eller behandling af udløste inflammatoriske reaktioner med tumor nekrosis faktor alfa antagonist.
EP3780002B1 (en) * 2010-11-24 2024-07-17 Clinical Ink, Inc. Systems and methods to assess cognitive function
UY35144A (es) 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
EP3907237A1 (en) 2012-12-20 2021-11-10 Amgen Inc. Apj receptor agonists and uses thereof
AU2014284496A1 (en) 2013-07-03 2016-01-21 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method for treating cognitive dysfunction
GB201311948D0 (en) 2013-07-03 2013-08-14 British American Tobacco Co Curling Machine
EP3024845A1 (en) 2013-07-25 2016-06-01 Novartis AG Cyclic polypeptides for the treatment of heart failure
WO2015013165A1 (en) * 2013-07-25 2015-01-29 Novartis Ag Cyclic apelin derivatives for the treatment of heart failure
WO2015013169A2 (en) 2013-07-25 2015-01-29 Novartis Ag Bioconjugates of synthetic apelin polypeptides

Similar Documents

Publication Publication Date Title
Sletov et al. Treatment of patients with surround defects mandible
JP6319847B2 (ja) 軸索再生を促進するための脊髄装置および方法
JP2017535342A (ja) 細胞活性及び修飾を誘導するためのデバイス
RU2493797C1 (ru) Имплантат для замещения дефектов нижней челюсти
Pickerill Facial surgery
CN208974063U (zh) 一种内置式弓形牵张成骨装置
RU2364378C1 (ru) Вправление вывиха плеча
Youn et al. Use of the pedicled buccal fat pad in the reconstruction of intraoral defects: a report of five cases
Aparna et al. Temporary obturator using high-density polyurethane foam following maxillectomy during the coronavirus disease 2019 pandemic
RU2268681C2 (ru) Способ изготовления съемного сложночелюстного протеза на верхнюю челюсть
Brauner et al. Osteoradionecrosis of a mandible: A case report of implant-supported rehabilitation
Conley et al. Pectoralis myocutaneous flap for chin augmentation
Naunheim et al. Placement of a 16-French voice prosthesis at the time of secondary tracheoesophageal voice restoration
RU2413468C1 (ru) Способ объемного замещения черпаловидного хряща
RU2682615C1 (ru) Устройство для фиксации фрагментов нижней челюсти у экспериментального животного
Kharade et al. Tongue and Palatal Augmentation Prosthesis
Huber Speech re-education following palatal reconstruction
RU2631050C1 (ru) Способ изготовления армированного базиса съёмного протеза
CN309654344S (zh) 神经挡开器
CN309685720S (zh) 牙科种植用不可吸收膜
YAMASHITA et al. Treatment progress of speech function in a glossectomized patient wearing PAP—Observation of speech intelligibility and ultrasound image—
Shevela et al. Rehabilitation of patients with oronasal communication after combined treatment of malignant neoplasms of the upper jaw
Kharade Introduction to Maxillofacial Rehabilitation
Bradford CONGENITAL DISLOCATION OF THE HIP: Results of Treatment at the Boston Children's Hospital.
袁本祥 The three-dimensional geometry the proximal humerus of Chinese and the influence to prosthetic design and surgical technique